About The Author
Thomas E. Keane, MD
Thomas E. Keane, MD, is Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston. Dr. Keane specializes in managing prostate, bladder, and renal cancers. An avid researcher, Dr. Keane has served as principal investigator or co-investigator on more than 20 major clinical and preclinical studies. Much of his work focuses on innovative concepts in translational research, including utilizing human tumor xenografts to investigate the efficacy of new therapies as they relate to GU malignancies with particular reference to cytotoxic agents, sphingolipids, and boron-containing compounds. He holds a United States patent for sphingolipid derivatives and their use. Dr. Keane’s research has led to publication of more than 100 articles peer-reviewed in such journals as The Journal of Urology, Urologic Oncology, and the Journal of Vascular Surgery. He provides editorial services to publications ranging from Urology to the International Journal of Cancer and is co-editor of the text Glenn’s Urologic Surgery, 6th, 7th, and 8th Editions. He is an accomplished speaker, having delivered many presentations to professional societies and symposia throughout the United States and abroad.
Join the GRU Community
- Why Join? -You have Successfully Subscribed!
CARDEN JENNINGS PUBLISHING CO., LTD.
375 Greenbrier Drive, Suite 100
Charlottesville, VA 22901
Call Us:
434-817-2000
Email Us:
Send Message
INFO
Privacy PolicyTerms & Conditions
Your GRU
Recent Updates
- PDF Embedder Test Jan 2022
- Genetic Testing and Prostate Cancer – Welcome Jan 2022
- Current Status of PSMA Diagnostics Aug 2021
- Genetic Testing and Prostate Cancer Aug 2021
- What’s New in Active Surveillance for Prostate Cancer in 2021 Aug 2021
Exercise & Wellness
Fred Bartlit, Esq.
StrongPath
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan